BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
BRAF
,
Fatty acid metabolic process
,
Obesity
,
Kidney
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interferon alfa-2a
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
IFNAR2
IFNAR1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Interferon/interleukin receptor domain
REACTOME_REGULATION_OF_IFNA_SIGNALING
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
PID_CD8_TCR_DOWNSTREAM_PATHWAY
REACTOME_INTERFERON_SIGNALING
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Effect of Ribavirin on Liver Gene Expression in Chronic Hepatitis C
Livers of chronic hepatitis C patients treated with PegIntron (pegIFNα-2b) or Pegasys (pegIFNα-2a)
Livers of chronic hepatitis B patients after combined treatment with peginterferon and adefovir
Liver biopsies of chronic hepatitis C patients treated with peg-IFNA-2a and ribavirin
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Treatment of Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A Retrospective Cha…
Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycyt…
Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B w…
Clinical effect and influencing factors of pegylated interferon alfa-2a and entecavir monotherapy am…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV I…
Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cance…
Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Bra…
Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ